Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 21
Filtrar
1.
Rev. esp. salud pública ; 97: e202312103, Dic. 2023. tab, graf
Artigo em Espanhol | IBECS | ID: ibc-229755

RESUMO

Fundamentos: A pesar de la reducción del número de personas fumadoras a nivel mundial, el consumo de tabaco de liar ha aumentado en los últimos años en muchos países, lo que puede frenar la tendencia descendente del hábito tabáquico. El objetivo de este trabajo fue analizar la evolución del número de personas que consumen tabaco de liar y tabaco de cualquier tipo entre 2013 y 2018 en el País Vasco y determinar si existían desigualdades socioeconómicas en su consumo. Métodos: Se realizó un estudio observacional y transversal de una muestra representativa de la población residente en el País Vasco de dieciséis a cincuenta y nueve años (n 2013=6.929 y n 2018=7.961) a partir de la Encuesta de Salud del País Vasco (años 2013 y 2018) y de la Encuesta sobre Adicciones de Euskadi (2018). Se calcularon las prevalencias de consumo habitual de tabaco en general y de tabaco de liar según diferentes variables socioeconómicas para los años 2013 y 2018, así como las razones de prevalencia para la estimación del cambio entre esos años y según las variables anteriores mediante modelos de regresión de Poisson robusto. Los análisis se estratificaron por sexo y por dos grupos de edad. RESULTADOS // La prevalencia de consumo de tabaco en general disminuyó entre 2013 (hombres=27,7% y mujeres=24,1%) y 2018 (hombres=24,1% y mujeres=18,6%), pero se mantuvo en el caso del consumo de tabaco de liar (en 2013, hombres=5,1% y mujeres=3,2%; en 2018, 5,4% y 3,5%, respectivamente). A diferencia del consumo de tabaco en general, que presentó un claro gradiente socioeconómico, el consumo de tabaco de liar fue más prevalente entre las personas jóvenes (en 2018, hombres=6,4% y mujeres=4,1%), grupo en el que el patrón por posición socioeconómica era menos evidente. Conclusiones: Considerando la persistencia en el consumo de tabaco de liar, es preciso dirigir también la lucha contra el tabaquismohacia...(AU)


Background: Despite the global reduction in smoking, the consumption of roll-your-own tobacco has increased in recent years in many countries, which may be slowing down the downward trend in smoking. The aim of this paper was to analyse the evolution of the number of people who use roll-your-own tobacco and tobacco of any type between 2013 and 2018 in the Basque Country and measure whether there were socioeconomic inequalities in its consumption. Methods: We carried out an observational and cross-sectional study of a representative sample of the population living in the Basque Country aged 16 to 59 years (n2013=6929 y n2018=7961) from the Basque Health Survey (2013 and 2018) and the Basque Addictions Survey (2018). We calculated prevalences of regular tobacco smoking in general and of roll-your-own cigarettes according to different socioeconomic variables for the years 2013 and 2018, as well as prevalence ratios for the estimation of change between these years and according to the above variables through robust Poisson regression models. We stratified analyses by sex and two age groups.Results: Overall smoking prevalence decreased between 2013 (men=27.7% and women=24.1%) and 2018 but remained the same for those who used roll-your-own tobacco (in 2013, men=5.1% and women=3.2%; in 2018=5.4% and 3.5%, respectively). In contrast to tobacco in general, which showed a clear socio-economic gradient, roll-your-own tobacco use was more prevalent among young people (in 2018, men=6.4% and women=4.1%), a group where the pattern by socio-economic status was less evident.Conclusions: Considering the persistence of roll-your-own tobacco consumption, we also should direct tobacco control towards this kind of product, and its use should be monitored and supervised, especially among young people.(AU)


Assuntos
Humanos , Masculino , Feminino , Uso de Tabaco/economia , Nicotiana , Fumar Produtos sem Tabaco , Espanha , Saúde Pública , Estudos Transversais , Inquéritos e Questionários
2.
Tob Control ; 31(4): 572-575, 2022 07.
Artigo em Inglês | MEDLINE | ID: mdl-33563703

RESUMO

OBJECTIVE: To assess the online availability and e-marketing strategies of herbal smoking products (HSPs). METHODOLOGY: Google, Yahoo and Bing were searched using relevant keywords related to HSPs. The first 50 records were retrieved and duplicates were removed. Two trained and calibrated authors screened the records according to the eligibility criteria and extracted data from each selected retail-webpage as per the pre-tested data extraction form. RESULTS: Out of the initial 1044 records obtained, 73 retail webpages were finally included. Most of the webpages about HSPs hailed from India followed by the USA. The results showed 24 brands with about 189 flavour variants that are readily available online to all age groups including minors, with price per pack (20 sticks) of herbal cigarettes ranging from INR (₹) 51 to 1830 (median 588). There are no regulations regarding the sale and marketing of HSPs concerning age restrictions and display of health warnings. CONCLUSION: HSPs are readily available online at affordable prices and attractive variants for customers of all ages. The flavour appeal and the health benefit appeal is being used to target minors and young women. There is an urgent need for some regulations on the sale and e-marketing of such products that have an enormous potential to be used as a gateway to tobacco smoking.


Assuntos
Marketing , Produtos do Tabaco , Comércio , Custos e Análise de Custo , Feminino , Aromatizantes , Humanos , Marketing/métodos , Fumar Produtos sem Tabaco
3.
Indian J Tuberc ; 68S: S71-S79, 2021.
Artigo em Inglês | MEDLINE | ID: mdl-34538396

RESUMO

BACKGROUND: Herbal smoking products (HSPs) are marketed as a safer alternative to tobacco. These are easily available at affordable prices in the online retail websites. This study aimed to analyze the HSP-related informational content available in the most popular online platforms. METHODS: Google, Yahoo, Bing and YouTube online platforms were searched for HSP related content using appropriate keywords. First 50 search results were retrieved and screened for potential eligibility. The included web-pages were categorized as video and still records. From each included record, information regarding source, primary theme, health benefits/hazards and tone was abstracted. Additionally, video production quality, like ratio and video power index was also computed for each video record. All included records were subjected to descriptive statistics and Chi-square test, as appropriate. Level of significance was set at <0.05. RESULTS: 174 still and 94 video records were included. 35.6% of the included still records were sourced by manufacturers/suppliers while that of scientific origin was 12.1%. 83% of the video-records were posted by general public. About 90% of the included records had not mentioned anything regarding age restrictions. 67.8% of the still records and 87.2% of the video records promoted the use of HSPs. CONCLUSIONS: The informational content presented online is huge, mostly posted by the general public without any scientific rationale and exclusively favors the use of HSPs. There is no age restriction as to who can access the information, making this content easily accessible to people of all ages. Such spread of information may mislead the public in adopting the smoking of these herbal products. Since HSPs may act as a potential gateway to tobacco smoking, there is an urgent need to regulate the content available online.


Assuntos
Abandono do Hábito de Fumar , Fumar , Humanos , Internet , Fumar Produtos sem Tabaco , Fumar Tabaco , Uso de Tabaco
4.
BMC Cancer ; 20(1): 807, 2020 Aug 26.
Artigo em Inglês | MEDLINE | ID: mdl-32842991

RESUMO

BACKGROUND: In recent years, lung cancer (LC) incidence has increased in Iran. The use of opium and its derivatives (O&D) has increased as well. This study aimed to investigate the association between the use of O&D and LC incidence. METHODS: In this case-control study conducted in Kerman, Iran; 140 patients with lung cancer and 280 healthy controls matched by age, sex, and place of residence were included. Data, including O&D use, cigarette smoking, alcohol use, and diet, were collected using a structured questionnaire. The relation between the use of O&D and LC was evaluated using conditional logistic regression adjusted for tobacco smoking, education, daily intake of fruit, vegetables, red meat, and hydrogenated fats. RESULTS: Opium ever-use was associated with an increased risk of LC (Adjusted Odds Ratio (AOR) =5.95, 95% CI: 1.87-18.92). Participants were divided into low and high use groups based on the median of opium use in the control group. A significant dose-response relation was observed between the amount of daily O&D use and LC; and the relation was stronger in high users (AOR low users = 3.81% CI: 1.13-12.77 and OR high users = 9.36, 95% CI: 2.05-42.72). Also, LC was higher among participants starting the use of O&D at younger ages (≤ 41 years old vs never users AOR = 8.64, 95% CI: 1.90-39.18) compared to those who started at an older age (> 41 years old vs never users, AOR = 4.71, 95% CI: 1.38-16.08). The association between opium, and lung cancer among non-smokers was OR: 6.50 (95% CI: 2.89 to 14.64). CONCLUSION: The results of this study show that opium use is probably a dose related risk factor for lung cancer.


Assuntos
Neoplasias Pulmonares/epidemiologia , Ópio/efeitos adversos , Fumar Produtos sem Tabaco/epidemiologia , Fatores Etários , Idoso , Consumo de Bebidas Alcoólicas/efeitos adversos , Consumo de Bebidas Alcoólicas/epidemiologia , Estudos de Casos e Controles , Fumar Cigarros/efeitos adversos , Fumar Cigarros/epidemiologia , Feminino , Voluntários Saudáveis , Humanos , Irã (Geográfico)/epidemiologia , Neoplasias Pulmonares/etiologia , Masculino , Pessoa de Meia-Idade , não Fumantes/estatística & dados numéricos , Sistema de Registros/estatística & dados numéricos , Fatores de Risco , Fumantes/estatística & dados numéricos , Fumar Produtos sem Tabaco/efeitos adversos
6.
Adv Respir Med ; 88(2): 142-146, 2020.
Artigo em Inglês | MEDLINE | ID: mdl-32383466

RESUMO

Acute eosinophilic pneumonia (AEP) is characterized by an acute onset respiratory illness with bilateral chest infiltrates and evidence of pulmonary eosinophilia. Cigarette smoking is the main risk factor, but drugs and other inhalational exposures have also been reported. Herein, the association between AEP and smoking devices other than cigarettes is reviewed The PubMed database was searched using terms such as "smoking", "vaping", "e-cigarette", "waterpipe", and "marijuana", along with other commonly used synonyms for these terms. In addition, eosinophilic lung diseases were also searched for using the same database. All cases of AEP were identified using the modified Philit criteria in association with the use of marijuana, waterpipe, e-cigarettes or heat-not-burn cigarettes. Cases associated with illicit drug use were excluded. Twelve cases were included with amedian age of 20 (15-60). 75% of patients studied were male. Exposures included marijuana smoking (n = 5), waterpipe usage (n = 2), heat-not-burn cigarette use (n = 2), e-cigarette use (n = 2) and synthetic cannabinoid use (n = 1). Arecent change in smoking habits was reported in 50% of patients. Presenting symptoms were dyspnea (91.6%), cough (66.6%), fever (66.6%) and chest pain (25%). 90% of patients had leukocytosis on presentation, but only 16.6% had peri-pheral eosinophilia. The median eosinophil percentage in bronchoalveolar lavage was 67.5% (0 to 78). Two patients had alung biopsy performed. Bilateral involvement on chest imaging was reported in all patients. Five patients (41.6%) required invasive mechanical ventilation and ten patients (83.3%) were treated in an intensive care unit. All patients responded to corticosteroid therapy with no relapses reported. Acute eosinophilic pneumonia is reported with smoking that does not include traditional cigarette smoking such as waterpipes, e-cigarettes, heat-not-burn cigarettes, and marijuana and can have asimilar presentation and clinical course.


Assuntos
Eosinofilia Pulmonar/induzido quimicamente , Fumar Produtos sem Tabaco/efeitos adversos , Fumar/efeitos adversos , Adolescente , Adulto , Sistemas Eletrônicos de Liberação de Nicotina/estatística & dados numéricos , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Eosinofilia Pulmonar/diagnóstico , Eosinofilia Pulmonar/tratamento farmacológico , Testes de Função Respiratória , Fumar Produtos sem Tabaco/tratamento farmacológico , Adulto Jovem
7.
Cardiovasc J Afr ; 31(5): 241-244, 2020.
Artigo em Inglês | MEDLINE | ID: mdl-32140699

RESUMO

OBJECTIVE: The aim of this study was to investigate the effects of heroin addiction, which is an important social and health problem, on right cardiac function. METHODS: A total of 85 individuals were included in the study. The study group comprised 45 patients smoking heroin and the control group was 40 healthy individuals with no drug addiction. Patients injecting heroin were excluded. Echocardiographic evaluation of patients using heroin was performed and compared with those in the control group. RESULTS: The right ventricle and pulmonary artery diameters in the heroin group were found to be higher compared to the control group. The myocardial performance index (MPI) was higher and more abnormal in the heroin group (0.48 ± 0.22 vs 0.39 ± 0.11, p < 0.05) whereas isovolumic acceleration (IVA) of the right ventricle was significantly lower in the heroin group (2.92 ± 0.69 vs 3.4 ± 0.68 m/s2, p < 0.01). No significant difference was observed between the groups with regard to the right ventricular ejection fraction (RVEF) (59.6 ± 2.5 vs 60.6 ± 2.3%, p = 0.08), tricuspid annular plain systolic excursion (TAPSE) (24.1 ± 4.2 vs 24.5 ± 2.4 mm, p = 0.7), tissue Doppler imaging S wave (TDI-S) (13.7 ± 2.1 vs 13.8 ± 2.1 cm/s, p = 0.86) and right ventricular fractional area change (RVFAC) (42.7 ± 8.3 vs 43.9 ± 3.5%, p = 0.4). Multivariate and univariate regression analyses revealed independent correlation between the pulmonary artery diameter and RVIVA, and heroin addiction. CONCLUSIONS: Heroin addiction negatively affected right ventricular function and more attention should be paid to the cardiac function of these patients.


Assuntos
Dependência de Heroína/complicações , Fumar Produtos sem Tabaco/efeitos adversos , Disfunção Ventricular Direita/etiologia , Função Ventricular Direita/efeitos dos fármacos , Adulto , Ecocardiografia Doppler , Feminino , Dependência de Heroína/diagnóstico , Humanos , Masculino , Estudos Retrospectivos , Disfunção Ventricular Direita/diagnóstico por imagem , Disfunção Ventricular Direita/fisiopatologia , Adulto Jovem
8.
Cancer Epidemiol Biomarkers Prev ; 29(3): 650-658, 2020 03.
Artigo em Inglês | MEDLINE | ID: mdl-31915141

RESUMO

BACKGROUND: There is little information on human exposure to carcinogens and other toxicants related to opiate use, alone or in combination with tobacco. METHODS: Among male participants of the Golestan Cohort Study in Northeast Iran, we studied 28 never users of either opiates or tobacco, 33 exclusive cigarette smokers, 23 exclusive users of smoked opiates, and 30 opiate users who also smoked cigarettes (dual users; 21 smoked opiates and 9 ingested them). We quantified urinary concentrations of 39 exposure biomarkers, including tobacco alkaloids, tobacco-specific nitrosamines, polycyclic aromatic hydrocarbons (PAH), and volatile organic compounds (VOC), and used decomposition to parse out the share of the biomarker concentrations explained by opiate use and nicotine dose. RESULTS: Dual users had the highest concentrations of all biomarkers, but exclusive cigarette smokers and exclusive opiate users had substantially higher concentrations of PAH and VOC biomarkers than never users of either product. Decomposition analysis showed that opiate use contributed a larger part of the PAH concentrations than nicotine dose, and the sum of 2- and 3-hydroxyphenanthrene (∑2,3-phe) resulted almost completely from opiate use. Concentrations of most VOC biomarkers were explained by both nicotine dose and opiate use. Two acrylamide metabolites, a 1,3-butadiene metabolite and a dimethylformamide metabolite, were more strongly explained by opiate use. Acrylamide metabolites and ∑2,3-phe were significantly higher in opiate smokers than opiate eaters; other biomarkers did not vary by the route of opiate intake. CONCLUSIONS: Both cigarette smokers and opiate users (by smoking or ingestion) were exposed to many toxicants and carcinogens. IMPACT: This high exposure, particularly among dual opiate and cigarette users, can have a substantial global public health impact.


Assuntos
Carcinógenos/análise , Fumar Cigarros/efeitos adversos , Alcaloides Opiáceos/toxicidade , Fumar Produtos sem Tabaco/efeitos adversos , Produtos do Tabaco/toxicidade , Administração Oral , Adulto , Biomarcadores/urina , Carcinógenos/toxicidade , Fumar Cigarros/urina , Estudos de Coortes , Humanos , Irã (Geográfico) , Masculino , Pessoa de Meia-Idade , Alcaloides Opiáceos/administração & dosagem , Fumar Produtos sem Tabaco/urina
9.
Chest ; 157(3): 558-565, 2020 03.
Artigo em Inglês | MEDLINE | ID: mdl-31759961

RESUMO

BACKGROUND: Heroin smokers have high rates of COPD, respiratory morbidity, hospital admission, and mortality. We assessed the natural history of symptoms and lung function in this population over time. METHODS: A cohort of heroin smokers with COPD was followed for 18 to 24 months. At baseline and follow-up, respiratory symptoms were measured by the Medical Research Council Dyspnea Scale (MRC) and the COPD Assessment Tool (CAT), and postbronchodilator spirometry was performed. Frequency of health-care-seeking episodes was extracted from routine health records. Parametric, nonparametric, and linear regression models were used to analyze the change in symptoms and lung function over time. RESULTS: Of 372 participants originally recruited, 161 were assessed at follow-up (mean age, 51.0 ± 5.3 years; 74 women [46%]) and 106 participants completed postbronchodilator spirometry. All participants were current or previous heroin smokers, and 122 (75.8%) had smoked crack. Symptoms increased over time (MRC score increased by 0.48 points per year, P < .001; CAT score increased by 1.60 points per year, P < .001). FEV1 declined annually by 90 ± 190 mL (P < .001). This deterioration was not associated with change in tobacco or heroin smoking status or use of inhaled medications. CONCLUSIONS: Heroin smokers experience a high and increasing burden of chronic respiratory symptoms and a decline in FEV1 that exceeds the normal age-related decline observed among tobacco smokers with COPD and healthy nonsmokers. Targeted COPD diagnostic and treatment services hosted within opiate substitution services could benefit this vulnerable, relatively inaccessible, and underserved group of people.


Assuntos
Dependência de Heroína/fisiopatologia , Pulmão/fisiopatologia , Doença Pulmonar Obstrutiva Crônica/fisiopatologia , Fumar Produtos sem Tabaco/fisiopatologia , Broncodilatadores/uso terapêutico , Fumar Cigarros/epidemiologia , Fumar Cigarros/fisiopatologia , Fumar Cocaína/epidemiologia , Fumar Cocaína/fisiopatologia , Estudos de Coortes , Progressão da Doença , Serviço Hospitalar de Emergência/estatística & dados numéricos , Feminino , Volume Expiratório Forçado , Dependência de Heroína/tratamento farmacológico , Dependência de Heroína/epidemiologia , Hospitalização/estatística & dados numéricos , Humanos , Estudos Longitudinais , Masculino , Fumar Maconha/epidemiologia , Fumar Maconha/fisiopatologia , Programas de Rastreamento , Pessoa de Meia-Idade , Tratamento de Substituição de Opiáceos , Atenção Primária à Saúde/estatística & dados numéricos , Doença Pulmonar Obstrutiva Crônica/epidemiologia , Índice de Gravidade de Doença , Fumar Produtos sem Tabaco/epidemiologia , Espirometria
10.
BMC Womens Health ; 18(1): 154, 2018 09 24.
Artigo em Inglês | MEDLINE | ID: mdl-30249233

RESUMO

BACKGROUND: By 2030, the Sub-Saharan African region is projected to be the epicenter of the tobacco epidemic. While smoking prevalence is currently low among women (< 2%), the prevalence among men (7.7% overall and up to 27% depending on region) makes exposure to secondhand smoke a pressing concern for women and children. To prevent the uptake of smoking among women and address tobacco-related risks, including secondhand smoke exposure, a greater understanding of women's related perceptions is needed. The purpose of this study was to explore Ethiopian women's knowledge, attitudes, and beliefs related to tobacco use and secondhand smoke exposure, and the potential influence of contextual factors including; khat use, exposure to pro- and anti-tobacco messaging, and religious affiliation. METHODS: A cross-sectional study using a systematic household sampling technique and an adapted interviewer-administered survey was conducted in Southern Ethiopia. The survey was administered to 353 women, 18-55 years of age, in Aleta Wondo town and surrounding districts between August-October 2014 (95.2% cooperation rate). RESULTS: General awareness of harm associated with personal tobacco use and exposure to secondhand smoke was high (> 94%); however, specific knowledge of associated health-risks was limited. More than 96% perceived female tobacco use as socially unacceptable. At the same time, more than 70% were able to name potential benefits of using tobacco for both personal consumption and non-personal use. Respondents reported greater experimentation with khat versus tobacco and 73% reported that their religion significantly influenced their tobacco-related attitudes. Overall, there were higher reports of exposure to anti-tobacco (70%) versus pro-tobacco (49%) messaging, in the last 30 days. CONCLUSIONS: The high level of awareness of health risks associated with tobacco use and SHS exposure and the high exposure to anti-tobacco messaging are community-level strengths that can proactively be built on to prevent the projected disease burden associated with tobacco. Findings have implications for the development of contextualized gender-specific tobacco control interventions, particularly in relation to the promotion of smoke-free homes.


Assuntos
Publicidade , Conhecimentos, Atitudes e Prática em Saúde , Poluição por Fumaça de Tabaco/efeitos adversos , Fumar Tabaco/efeitos adversos , Adolescente , Adulto , Catha , Estudos Transversais , Etiópia , Feminino , Humanos , Pessoa de Meia-Idade , Percepção , Prevalência , Religião , Fumar Produtos sem Tabaco , Inquéritos e Questionários , Adulto Jovem
11.
Drug Test Anal ; 10(10): 1590-1598, 2018 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-29877063

RESUMO

The increased availability of high purity crystalline methamphetamine (MA) in Australia raised concerns because of high dosages and its potential consumption through inhalation. The present work investigates the possibility of using wastewater levels of N,N-dimethylamphetamine (DMA), a pyrolysis by-product, as an indirect indicator of MA smoking. A dedicated liquid chromatography quadrupole-time-of-flight mass spectrometry (LC-QToF-MS) method was set up to detect and quantify DMA in wastewater samples. Wastewater samples were collected from 8 locations across Australia during the period 2011-2016. Data about the abundance of DMA in MA seizures as well as in residues from drug paraphernalia were obtained from forensic laboratories in Australia. DMA/MA ratios measured in wastewater ranged from 0.0001 to 0.09 (median 0.007). DMA/MA ratios in bulk seizures are generally below 0.0025, with a median value of 0.0004, whilst residues in paraphernalia ranged from 0.031 to 3.37. DMA/MA ratios in wastewater decreased between 2011 and 2016, in parallel to an increase in MA loads. Furthermore, wastewater analyses highlighted a strong positive correlation between DMA/MA ratios and per capita MA use (Pearson's correlation ρ= 0.61, p-value <0.001). Nonetheless, geographical specificities could be highlighted between the investigated locations. The obtained data could help authorities detect hot spots of drug use as well as to plan specific intervention campaigns to tackle the issue. In future, simultaneous analysis of DMA and MA in both wastewater and seizures could improve our understanding about MA use and its consumption patterns.


Assuntos
Estimulantes do Sistema Nervoso Central/análise , Metanfetamina/análogos & derivados , Detecção do Abuso de Substâncias/métodos , Águas Residuárias/análise , Poluentes Químicos da Água/análise , Austrália/epidemiologia , Cromatografia Líquida/métodos , Humanos , Limite de Detecção , Espectrometria de Massas/métodos , Metanfetamina/análise , Pirólise , Fumar Produtos sem Tabaco/epidemiologia , Transtornos Relacionados ao Uso de Substâncias/epidemiologia
13.
Drug Test Anal ; 10(6): 917-926, 2018 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-29675893

RESUMO

The increase in opioid prescribing in many European countries over the last decade has raised concerns about associated diversion, overdose, and mortality. Fentanyl is one of these synthetic opioids that is typically prescribed as a transdermal patch for pain that requires continuous pain relief and has been the focus of investigation due to reports of overdose and death. We report a case series of 14 drug addiction treatment entrants, who entered treatment in a service located in the region of Southern Denmark from August 2015 to December 2015 for smoking fentanyl patches. Clients presented with difficulties breathing and pains in the lungs. The clients had a history of past opioid use, including heroin. Relapses resulted in treatment disengagement. Immunoassays for fentanyl were used in the service. In some cases, false negative results occurred. Clients' urine samples were subsequently analysed in a collaborating laboratory. Seven clients tested positive for fentanyl. One client was positive for both fentanyl and heroin. Analyses were also positive for other opioids and metabolites in 6 clients, predominantly codeine and oxycodone. Results from confirmatory analysis contributed to clearer insights into clients' drug histories, which facilitated personalised care plans consisting of opioid agonist therapy informed by confirmed drug use. In Denmark, prescription levels of fentanyl are high, which has been accompanied by observations of diversion and smoking in a smaller population. In addition to revision of inappropriate prescribing to reduce diversion, we recommend increased reliance upon confirmatory drug analysis in the addiction treatment sector in Denmark.


Assuntos
Fentanila/administração & dosagem , Fentanila/urina , Detecção do Abuso de Substâncias , Adesivo Transdérmico , Adulto , Analgésicos Opioides/administração & dosagem , Analgésicos Opioides/efeitos adversos , Analgésicos Opioides/urina , Feminino , Fentanila/efeitos adversos , Humanos , Imunoensaio , Masculino , Derivados da Morfina/administração & dosagem , Derivados da Morfina/efeitos adversos , Derivados da Morfina/urina , Estudos Retrospectivos , Fumar Produtos sem Tabaco/efeitos adversos , Fumar Produtos sem Tabaco/urina , Detecção do Abuso de Substâncias/estatística & dados numéricos , Adulto Jovem
14.
Psychopharmacology (Berl) ; 235(4): 1083-1092, 2018 04.
Artigo em Inglês | MEDLINE | ID: mdl-29306962

RESUMO

AIMS: Little is known about features of e-cigarettes (EC) that facilitate or hinder the switch from smoking to vaping. We tested eight brands of EC to determine how nicotine delivery and other product characteristics influence user's initial reactions. METHODS: Fifteen vapers tested each product after overnight abstinence from both smoking and vaping. At each session, participant's vaped ad lib for 5 min. Blood samples were taken at baseline and at 2, 4, 6, 8, 10 and 30 min after starting vaping. Participants rated the products on a range of characteristics. The products tested included six 'cig-a-like' and two refillable products, one with variable voltage. We also tested participants' own EC. RESULTS: All products significantly reduced urges to smoke. Refillable products delivered more nicotine and received generally superior ratings in terms of craving relief, subjective nicotine delivery, throat hit and vapour production but in overall ratings, they were joined by a cig-a-like, Blu. Participants puffed more on low nicotine delivery products. Participants' estimates of nicotine delivery from different EC were closely linked to 'throat hit'. Nicotine delivery was less important in the initial product ratings than draw resistance, mouthpiece comfort and effects on reducing urge to smoke. CONCLUSIONS: All EC products reduced urges to smoke. Refillable products received generally more favourable ratings than 'cig-a-likes' with similar nicotine content. Perception of nicotine delivery was guided by throat sensations. Lower nicotine delivery was associated with more frequent puffing. The first impressions of EC products are guided less by nicotine delivery than by sensory signals.


Assuntos
Comportamento do Consumidor , Sistemas Eletrônicos de Liberação de Nicotina/métodos , Nicotina/administração & dosagem , Percepção/fisiologia , Fumar Produtos sem Tabaco/psicologia , Vaping/psicologia , Adulto , Fissura/efeitos dos fármacos , Fissura/fisiologia , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Nicotina/sangue , Percepção/efeitos dos fármacos , Abandono do Hábito de Fumar/métodos , Abandono do Hábito de Fumar/psicologia , Fumar Produtos sem Tabaco/sangue , Vaping/sangue
15.
J Pharm Biomed Anal ; 150: 162-168, 2018 Feb 20.
Artigo em Inglês | MEDLINE | ID: mdl-29245085

RESUMO

Each year, synthetic cannabinoids are occurring in high numbers on the illicit drug market but data obtained after controlled application are rare. The present study on pharmacokinetics in urine is part of a pilot study on adverse effects of JWH-018, which is one of the oldest and best known synthetic cannabinoids. Six subjects inhaled smoke from 2 and 3mg JWH-018. The drug and ten potential metabolites were analyzed in urine samples collected during 12h after inhalation by liquid chromatography-mass spectrometry (LC-MS/MS) without and with conjugate cleavage. The parent compound was not detectable, but 13 of its metabolites, all of which were conjugated. Concentrations of the predominant metabolite, JWH-018 pentanoic acid, were less than 5ng/ml, but in two subjects it was still detected up to 4 weeks after ingestion. Other major metabolites were 5- and 4-HOpentyl-JWH-018, JWH-073 butanoic acid and a hypothetically dihydroxylated and dehydrogenated metabolite of JWH-018. Occasionally, further hydroxylated metabolites were found. Generally, hydroxylated metabolites were detected in concentrations lower than 1ng/ml already 10h after inhalation. All concentrations were much lower than reported for urine samples of authentic JWH-018 users. The formation of the metabolite JWH-018 pentanoic acid was found to be slightly delayed, but its rather high concentrations and detection over several weeks after single dosing makes it a useful target for urine analysis. The different excretion of carboxylic acid and hydroxylated metabolites may aid in evaluation of time of use.


Assuntos
Canabinoides/urina , Indóis/urina , Naftalenos/urina , Eliminação Renal , Fumar Produtos sem Tabaco , Biomarcadores/urina , Biotransformação , Butiratos/urina , Canabinoides/administração & dosagem , Canabinoides/síntese química , Canabinoides/farmacocinética , Cromatografia Líquida , Estudos Cross-Over , Feminino , Humanos , Hidroxilação , Indóis/administração & dosagem , Indóis/síntese química , Indóis/farmacocinética , Exposição por Inalação , Masculino , Naftalenos/administração & dosagem , Naftalenos/síntese química , Naftalenos/farmacocinética , Ácidos Pentanoicos/urina , Projetos Piloto , Espectrometria de Massas em Tandem , Urinálise , Adulto Jovem
16.
Addict Behav ; 79: 203-212, 2018 04.
Artigo em Inglês | MEDLINE | ID: mdl-29173942

RESUMO

The development and validation of survey measures for electronic nicotine and non-nicotine delivery system (ENDS) use has not kept pace with the burgeoning research on them. This, along with the diverse and evolving nature of ENDS, presents several unique measurement challenges and hampers surveillance and tobacco regulatory research efforts. In this commentary, we identify four important areas related to ENDS use (describing ENDS products; defining current use; evaluating frequency and quantity of use; and characterizing devices and e-liquids) and summarize a selective review of the measurement and definitions of these constructs across prominent national tobacco use surveys and 30 projects within the 14 federally-funded Tobacco Centers of Regulatory Science. Across these national, regional, and local studies, there was considerable variability and relatively little consensus in ENDS use measures - thus highlighting the need for caution when comparing findings across studies or over time until more research is available to evaluate the sensitivity of findings to differing measures. Drawing from the nascent ENDS use measurement research literature and our experiences, we conclude with general considerations for measuring ENDS use for tobacco researchers as an initial step towards the development of consensus measures.


Assuntos
Fumar Produtos sem Tabaco , Vaping , Consenso , Sistemas Eletrônicos de Liberação de Nicotina , Humanos , Psicometria , Reprodutibilidade dos Testes , Inquéritos e Questionários
17.
Sud Med Ekspert ; 60(4): 18-20, 2017.
Artigo em Russo | MEDLINE | ID: mdl-28766523

RESUMO

The objective of the present study was the development of the morphological criteria for the diagnostics of fatal intoxication with the herbal smoking blends (spices) using the samples of the biological materials obtained from the victims of pyrrolidinovalerophenone poisoning. The samples were taken from 13 autopsied cadavers of 11 men and 2 women at the age from 26 to 39 years based at the Astrakhan Regional Bureau of Forensic Medical Expertise during the period from 21011 to 2015. The diagnosis of pyrrolidinvalerpphenon poisoning was verified to the letter. The materials obtained during the standard autopsy procedure were used for the forensic genetic studies in the combination with the mandatory routine forensic chemical investigations with the application of the gas chromatographic techniques. Polymorphism of the morphological picture was attributable to the differences in the chemical composition of the poisons and the combination of narcotic and alcoholic intoxication. The signs of chronic intoxication manifested themselves in the form of mixed gliosis and various lesions of brain neurons. The variety of clinical symptoms and the morphological picture of pyrrolidinovalerophenone poisoning are responsible for different forms of tanatogenesis which suggests the necessity of further research on the mechanisms underlying the toxic effects of herbal smoking blends.


Assuntos
Encéfalo/patologia , Intoxicação por Gás , Gliose , Pirrolidinas , Fumar Produtos sem Tabaco/patologia , Adulto , Intoxicação Alcoólica/patologia , Cromatografia Gasosa/métodos , Drogas Desenhadas/farmacologia , Drogas Desenhadas/toxicidade , Feminino , Toxicologia Forense/métodos , Intoxicação por Gás/etiologia , Intoxicação por Gás/patologia , Gliose/induzido quimicamente , Gliose/patologia , Humanos , Masculino , Pirrolidinas/farmacologia , Pirrolidinas/toxicidade
18.
J Anal Toxicol ; 41(6): 551-558, 2017 Jul 01.
Artigo em Inglês | MEDLINE | ID: mdl-28637216

RESUMO

Synthetic cannabinoids have become a ubiquitous challenge in forensic toxicology and seized drug analysis. Thermal degradation products have yet to be identified and evaluated for toxicity in comparison to parent and metabolic compounds. An investigation into these pyrolytic products, as the major route of ingestion is inhalation, may produce additional insight to understand the toxicity of synthetic cannabinoids. The pyrolysis of JWH-018 and 11 additional synthetic cannabinoids and six herbal plant substrates were conducted using an in-house constructed smoking simulator. After pyrolysis of herbal material alone, the plant substrate was spiked with the drug compounds to 2-5% w/w concentrations. Samples were collected, filtered, evaporated under nitrogen gas, reconstituted in methanol, and analyzed via gas chromatograph-mass spectrometer. Pyrolysis of the plant material alone produced 10 consistently observed compounds between the six plant species. The pyrolysis of the synthetic cannabinoids produced a total of 52 pyrolytic compounds, where 32 were unique to a particular parent compound and the remaining 20 were common products between multiple cannabinoids. The thermal degradation followed three major pathways that are outlined to assist in producing a predictive model for new synthetic cannabinoids that may arise in case samples. The observed pyrolytic products are also viable options for analysis in post mortem samples and the evaluation of toxicity.


Assuntos
Canabinoides/análise , Drogas Desenhadas/análise , Drogas Ilícitas/análise , Indóis/análise , Naftalenos/análise , Cromatografia Líquida , Toxicologia Forense , Cromatografia Gasosa-Espectrometria de Massas , Fumar Produtos sem Tabaco
19.
Breastfeed Med ; 12(6): 381-385, 2017.
Artigo em Inglês | MEDLINE | ID: mdl-28530453

RESUMO

Crystal methamphetamine (MA) is a potent psycho-stimulant that is increasingly used worldwide. It is highly addictive, is often made in clandestine laboratories, and can cause serious health issues in adults. Health professionals caring for women in the perinatal period must counsel women about the health risks to infants if they are exposed to MA in breast milk. Most guidelines recommend that women who have current or recent MA use do not breastfeed. This article explores approaches to breastfeeding advice in the context of MA use. Women who have made lifestyle changes, engaged well with services in the antenatal period, and are committed to drug counseling services after discharge from hospital may be supported to breastfeed if they are assessed as safe to do so. The importance of assessing each woman individually when developing infant feeding plans throughout the perinatal period is advocated.


Assuntos
Transtornos Relacionados ao Uso de Anfetaminas/etiologia , Aleitamento Materno , Tomada de Decisões , Aconselhamento Diretivo , Bem-Estar do Lactente , Comportamento Materno/psicologia , Metanfetamina/efeitos adversos , Mães , Fumar Produtos sem Tabaco/efeitos adversos , Adulto , Transtornos Relacionados ao Uso de Anfetaminas/metabolismo , Aleitamento Materno/métodos , Feminino , Humanos , Lactente , Fenômenos Fisiológicos da Nutrição do Lactente , Recém-Nascido , Masculino , Metanfetamina/análise , Cooperação do Paciente , Comportamento de Redução do Risco
20.
Drug Test Anal ; 9(5): 734-743, 2017 May.
Artigo em Inglês | MEDLINE | ID: mdl-27400773

RESUMO

Herbal smoking blends containing synthetic cannabinoids have become popular alternatives to marijuana. These products were previously sold in pre-packaged foil bags, but nowadays seizures usually contain synthetic cannabinoid powders together with unprepared plant materials. A question often raised by the Swedish police is how much smoking blend can be prepared from certain amounts of banned substance, in order to establish the severity of the crime. To address this question, information about the synthetic cannabinoid content in both the powder and the prepared herbal blends is necessary. In this work, an extraction procedure compatible with direct NMR quantification of synthetic cannabinoids in herbal smoking blends was developed. Extraction media, time and efficiency were tested for different carrier materials containing representative synthetic cannabinoids. The developed protocol utilizes a 30 min extraction step in d4 -methanol in presence of internal standard allowing direct quantitation of the extract using NMR. The accuracy of the developed method was tested using in-house prepared herbal smoking blends. The results showed deviations less than 0.2% from the actual content, proving that the method is sufficiently accurate for these quantifications. Using this method, ten synthetic cannabinoids present in sixty-three different herbal blends seized by the Swedish police between October 2012 and April 2015 were quantified. Obtained results showed a variation in cannabinoid contents from 1.5% (w/w) for mixtures containing MDMB-CHMICA to over 5% (w/w) for mixtures containing 5F-AKB-48. This is important information for forensic experts when making theoretical calculations of production quantities in legal cases regarding "home-made" herbal smoking blends. Copyright © 2016 John Wiley & Sons, Ltd.


Assuntos
Adamantano/análogos & derivados , Canabinoides/análise , Drogas Ilícitas/análise , Indazóis/análise , Indóis/análise , Espectroscopia de Ressonância Magnética/métodos , Preparações de Plantas/análise , Adamantano/análise , Humanos , Metanol/química , Fumar Produtos sem Tabaco/epidemiologia , Solventes/química , Suécia/epidemiologia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...